Rare diseases
Investigational molecules
Locations
Back to Germany1 491 clinical trials in Frankfurt, Germany across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease
GermanyStudy on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy
GermanyStudy of luspatercept in patients with low-risk myelodysplastic syndrome (MDS) who do not require blood transfusions and have not received erythropoiesis treatment
GermanyStudy on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy
GermanyStudy Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer
GermanyStudy of Pemigatinib for Patients with Advanced Intrahepatic Cholangiocarcinoma with FGFR2 Changes After Local Therapy
GermanyStudy on Budesonide Tablets for Treating Eosinophilic Esophagitis in Adults
GermanyStudy on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
GermanyStudy of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
GermanyStudy of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant
GermanyStudy of Inhaled Pirfenidone for Patients with Progressive Pulmonary Fibrosis
GermanyStudy on the Safety and Effectiveness of Elafibranor for Adults with Primary Sclerosing Cholangitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on hematologic malignancies and solid tumors, including innovative treatments for lymphoma, leukemia, and various gastrointestinal cancers.
Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Research initiatives examining treatments for inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis, with emphasis on long-term management approaches.
Focus on innovative therapeutic options for chronic inflammatory conditions.
Clinical investigations of treatments for rare conditions, including Von Willebrand Disease and Dravet Syndrome, exploring novel therapeutic approaches.
Development of targeted therapies for previously difficult-to-treat conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
